Orthobiologics Market to Witness Significant Growth by 2026

The market report titled ‘Global Orthobiologics Market - Size, Share and Forecast (2019 - 2026) produced by DataM Intelligence analyses the industry dynamics in this competitive space to provide a comprehensive analysis of the market opportunities.

Global Orthobiologics Market Dynamics
The global market for the orthobiologics Market is primarily driven by the rising geriatric population, prevalence of obesity, and increasing incidence of orthopedic disorders and musculoskeletal diseases. According to the United Nations (UN), an estimated 10% - 15% of all adults aged over 60 have some degree of Osteoarthritis, with the prevalence higher in women than men. According to WHO, in 2018, approximately 37.3 million falls are severe enough to require medical attention occurred. The most substantial morbidity is arising in people aged 65 years or older.

Request for the free sample of the research report - https://www.datamintelligence.com/research-report/orthobiologics-market

Global Orthobiologics Market Segmentation
By Product, the global Orthobiologics market is segmented into Bone Morphogenetic Proteins (BMP), Demineralized Bone Matrix (DBM), Synthetic Bone Substitutes, Viscosupplements, Allografts, Stem cell, and others. Viscosupplements segment holds the most significant market share in Orthobiologics.
By Application, the global Orthobiologics market is segmented into Osteoarthritis & Degenerative Arthritis, Spinal Fusion, Fracture Recovery, Soft Tissue Injuries, and Maxillofacial & Dental Applications. The Osteoarthritis & degenerative arthritis sector occupies the most significant Orthobiologics market share. It can be attributed to the presence of huge geriatric population, who are more prone to osteoarthritis. The United Nations estimated that by 2050 people aged over 60 will account for more than 20% of the world’s population, of which 15-20% (around 130 million people) are estimated to have symptomatic osteoarthritis. The spinal fusion segment is expected to be the fastest growing market share owing to the rising prevalence of spinal cord injuries, sports-related injuries, and accidents.
Global Orthobiologics Market Regional Analysis
North America is the dominant share in the global Orthobiologics market, and it is primarily attributed to factors such as the increasing incidence of spinal disorders, rise in the geriatric population and obese population, and higher awareness about minimally invasive surgeries. Moreover, its broad base of the patient population and the established healthcare infrastructure and the rising disposable income and higher investment in R&D activities contribute to the growth of North America’s share. According to the American Academy of Orthopaedic Surgeons (AAOS), an estimated 4.7 million Americans have undergone total knee arthroplasty (TKA), and 2.5 million have undergone total hip arthroplasty (THA) and are living with implants.
Asia-Pacific region is expected to be the fastest growing market during the forecast period, owing to the region’s rapidly improving healthcare infrastructure and the presence of a broad base of the target population. According to the International Osteoporosis Foundation (IOF), osteoporosis affects almost 70 million Chinese over the age of 50 and causes some 687,000 hip fractures in China each year.
Global Orthobiologics Market Company Trends
Key players are adopting strategies such as mergers and acquisitions, partnerships, and regional expansion to stand out as strong competitors in the market. New product drug, strong clinical pipeline and increasing R&D are other ways the leading players improve their market presence.
In May 2019, Anika Therapeutics, a global, integrated orthopedic and regenerative medicines company specializing in therapeutics based on its proprietary hyaluronic acid ("HA") technology, announced plans to showcase its regenerative medicine and orthobiologics portfolio at the 12th Biennial International Society of Arthroscopy, Knee Surgery and Orthopaedic Sports Medicine (ISAKOS) Congress.

Read more information about the report -https://www.datamintelligence.com/research-report/orthobiologics-market

Table of contents overview -

1. Global Orthobiologics Market -Scope and Methodology
2. Global Orthobiologics Market -Key Trends and Developments
3. Global Orthobiologics Market – Executive Summary
4. Global Orthobiologics Market – Market Dynamics
5. Global Orthobiologics Market – Industry Analysis
6. Global Orthobiologics Market – By Product
7. Global Orthobiologics Market – By Application
8. Global Orthobiologics Market – By End User
9. Global Orthobiologics Market – By Region
10. Global Orthobiologics Market – Competitive Landscape
11. Company Profiles
12. Global Orthobiologics Market – Premium Insights
13. Global Orthobiologics Market – DataM

Corporate Address
1st floor, Phoenix Tech Tower, Plot no: 14/46, Habsidguda, IDA-Uppal, Hyderabad-500039, Telangana

Email
info@datamintelligence.com

Phone
+1 877-441-4866

About DataM Intelligence

DataM Intelligence 4Market Research is a Market Intelligence and Business Research firm, based in India. It aims to bridge the two main aspects of a business decision - opinion and supportive data.

DMI is currently strengthening its cross-industrial database for sectors including Chemicals, Materials, Agriculture, Healthcare Services, Animal Nutrition, Consumer Goods, Food & Beverages, Industrial Machinery and Automation among others.

This release was published on openPR.